• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

Introduction to 2-(2-chloropyrimidin-5-yl)propan-2-ol (CAS No. 110100-09-9)

2-(2-chloropyrimidin-5-yl)propan-2-ol, identified by its Chemical Abstracts Service (CAS) number 110100-09-9, is a significant compound in the realm of pharmaceutical and chemical research. This compound belongs to the class of pyrimidine derivatives, which have garnered considerable attention due to their diverse biological activities and potential applications in drug development. The structural features of this molecule, particularly the presence of a chloropyrimidine moiety linked to a propanol group, make it a versatile intermediate in synthetic chemistry and a candidate for further exploration in medicinal chemistry.

The chloropyrimidin-5-yl substituent in the molecular structure of 2-(2-chloropyrimidin-5-yl)propan-2-ol plays a crucial role in its reactivity and biological interactions. Pyrimidine derivatives are well-known for their involvement in various biological pathways, including DNA synthesis and repair, which has led to their extensive use in the development of antiviral, anticancer, and antimicrobial agents. The chlorine atom at the 2-position of the pyrimidine ring enhances the electrophilicity of the ring, making it susceptible to nucleophilic substitution reactions, thereby facilitating further functionalization.

The propan-2-ol moiety at the other end of the molecule introduces a hydroxyl group that can participate in hydrogen bonding interactions, influencing both the solubility and binding affinity of the compound. This dual functionality makes 2-(2-chloropyrimidin-5-yl)propan-2-ol a valuable building block for designing novel molecules with tailored properties. In recent years, there has been growing interest in modifying pyrimidine derivatives to improve their pharmacokinetic profiles and therapeutic efficacy.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the biological activity of compounds like 2-(2-chloropyrimidin-5-yl)propan-2-ol with greater accuracy. These tools have been instrumental in identifying potential drug candidates by simulating their interactions with biological targets such as enzymes and receptors. For instance, studies have shown that pyrimidine-based compounds can inhibit kinases, which are key enzymes involved in cell signaling pathways associated with diseases like cancer.

In the context of drug discovery, 2-(2-chloropyrimidin-5-yl)propan-2-ol has been explored as a precursor for synthesizing more complex molecules with enhanced biological activity. Researchers have utilized its reactive sites to introduce additional functional groups or link it to other pharmacophores, creating hybrid compounds that exhibit improved therapeutic effects. The flexibility offered by its structure allows for diverse chemical modifications, making it a promising candidate for further investigation.

The synthesis of 2-(2-chloropyrimidin-5-yl)propan-2-ol typically involves multi-step organic reactions starting from readily available pyrimidine derivatives. The chlorination step at the 5-position of the pyrimidine ring is often achieved using chlorinating agents such as phosphorus oxychloride or thionyl chloride. Subsequently, the introduction of the propanol group can be accomplished through nucleophilic addition reactions or other synthetic strategies depending on the desired purity and yield.

One of the most compelling aspects of studying compounds like 2-(2-chloropyrimidin-5-yl)propan-2-ol is their potential application in addressing unmet medical needs. The ongoing COVID-19 pandemic has highlighted the importance of rapid drug development pipelines, and compounds derived from pyrimidine scaffolds have been among those under intense scrutiny. Researchers are leveraging computational methods to screen large libraries of such derivatives for compounds that can modulate viral replication or immune responses.

The structural versatility of 2-(2-chloropyrimidin-5-yl)propan-2-ol also makes it an attractive candidate for developing kinase inhibitors, which are critical in targeted cancer therapies. By fine-tuning its structure through rational drug design, scientists aim to create molecules that selectively inhibit aberrant signaling pathways without affecting normal cellular processes. This approach has led to several successful drugs that have significantly improved patient outcomes.

In conclusion, 2-(2-chloropyrimidin-5-yloxypropyl alcohol (CAS No. 11010009) represents a fascinating compound with immense potential in pharmaceutical research. Its unique structural features and reactivity make it a valuable tool for synthesizing novel therapeutic agents. As our understanding of biological systems continues to evolve, compounds like this will play an increasingly important role in addressing complex diseases and improving global health.

• 1383803-14-2(1-(2-Chloropyrimidin-5-yl)-3-methylbutan-1-ol)
• 596114-50-0(2-Chloro-5-isopropylpyrimidine)
• 1046816-75-4((2-Chloropyrimidin-5-yl)methanol)
• 1314390-24-3(2-Chloro-5-(1-methoxy-1-methylethyl)pyrimidine)
• 126230-70-4(5-Pyrimidinemethanol, alpha,alpha-dimethyl- (9CI))
• 1279822-48-8(1-(2-Chloropyrimidin-5-yl)ethan-1-ol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)